Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Xieli Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale production of plant-derived Active Pharmaceutical Ingredients (APIs) and intermediates. Founded in 1998 and headquartered in Changsha, the company is recognized as a leading global supplier of bioflavonoids, including Rutin, Quercetin, Troxerutin, and Diosmin. Their manufacturing facilities are GMP-certified, and the company holds several international quality certifications, such as the European Certificate of Suitability (CEP), enabling broad export capabilities to Europe, North America, and Southeast Asia. In addition to its core API business, Hunan Xieli provides contract manufacturing services and focuses on high-purity natural product extraction technologies. The company is a key player in the global supply chain for vascular health and dietary supplement ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Xieli Pharmaceutical.